Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ... International journal of antimicrobial agents 56 (1), 105949, 2020 | 6572 | 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 P Colson, JM Rolain, JC Lagier, P Brouqui, D Raoult International journal of antimicrobial agents 55 (4), 105932, 2020 | 1184 | 2020 |
Endocarditis due to rare and fastidious bacteria P Brouqui, D Raoult Clinical microbiology reviews 14 (1), 177-207, 2001 | 978 | 2001 |
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study P Gautret, JC Lagier, P Parola, L Meddeb, J Sevestre, M Mailhe, ... Travel medicine and infectious disease 34, 101663, 2020 | 923 | 2020 |
Recommendations for Treatment of Human Infections Caused by Bartonella Species JM Rolain, P Brouqui, JE Koehler, C Maguina, MJ Dolan, D Raoult Antimicrobial agents and chemotherapy 48 (6), 1921-1933, 2004 | 637 | 2004 |
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France M Million, JC Lagier, P Gautret, P Colson, PE Fournier, S Amrane, ... Travel medicine and infectious disease 35, 101738, 2020 | 575 | 2020 |
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe P Brouqui, F Bacellar, G Baranton, RJ Birtles, A Bjoersdorff, JR Blanco, ... Clinical microbiology and infection 10 (12), 1108-1132, 2004 | 573 | 2004 |
Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine D Raoult, P Houpikian, HT Dupont, JM Riss, J Arditi-Djiane, P Brouqui Archives of Internal Medicine 159 (2), 167-173, 1999 | 441 | 1999 |
Novel chikungunya virus variant in travelers returning from Indian Ocean islands P Parola, X De Lamballerie, J Jourdan, C Rovery, V Vaillant, P Minodier, ... Emerging infectious diseases 12 (10), 1493, 2006 | 434 | 2006 |
Human disease in Europe caused by a granulocytic Ehrlichia species M Petrovec, S Lotric Furlan, TA Zupanc, F Strle, P Brouqui, V Roux, ... Journal of Clinical Microbiology 35 (6), 1556-1559, 1997 | 428 | 1997 |
Bartonella (Rochalimaea) quintana endocarditis in three homeless men M Drancourt, JL Mainardi, P Brouqui, F Vandenesch, A Carta, F Lehnert, ... New England Journal of Medicine 332 (7), 419-423, 1995 | 425 | 1995 |
Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases HT Dupont, D Raoult, P Brouqui, F Janbon, D Peyramond, PJ Weiller, ... The American journal of medicine 93 (4), 427-434, 1992 | 418 | 1992 |
Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases F Simon, P Parola, M Grandadam, S Fourcade, M Oliver, P Brouqui, ... Medicine 86 (3), 123-137, 2007 | 411 | 2007 |
A new strategy to fight antimicrobial resistance: the revival of old antibiotics N Cassir, JM Rolain, P Brouqui Frontiers in microbiology 5, 109581, 2014 | 371 | 2014 |
Chronic Bartonella quintana bacteremia in homeless patients P Brouqui, B Lascola, V Roux, D Raoult New England Journal of Medicine 340 (3), 184-189, 1999 | 355 | 1999 |
Detection of ehrlichiae in African ticks by polymerase chain reaction P Parola, V Roux, JL Camicas, I Baradji, P Brouqui, D Raoult Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (6 …, 2000 | 331 | 2000 |
Infections in the homeless D Raoult, C Foucault, P Brouqui The Lancet infectious diseases 1 (2), 77-84, 2001 | 329 | 2001 |
Chronic Q fever: ninety-two cases from France, including 27 cases without endocarditis P Brouqui, HT Dupont, M Drancourt, Y Berland, J Etienne, C Leport, ... Archives of internal medicine 153 (5), 642-648, 1993 | 326 | 1993 |
Bedbugs and infectious diseases P Delaunay, V Blanc, P Del Giudice, A Levy-Bencheton, O Chosidow, ... Clinical Infectious Diseases 52 (2), 200-210, 2011 | 307 | 2011 |
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis JC Lagier, M Million, P Gautret, P Colson, S Cortaredona, ... Travel medicine and infectious disease 36, 101791, 2020 | 302 | 2020 |